Related Experiment Videos
Dopamine requires ascorbic acid to be the prolactin release-inhibiting factor
The American Journal of Physiology
|October 8, 1997
Summary
Dopamine normally inhibits prolactin release but loses effectiveness over time. Ascorbic acid enhances dopamine's prolactin-inhibiting action by preventing receptor downregulation in pituitary cells.
Area of Science:
- Endocrinology
- Cell Biology
Background:
- Dopamine is a key regulator of prolactin secretion from the pituitary gland.
- Prolactin plays a crucial role in lactation and other physiological processes.
- The precise mechanisms underlying dopamine's inhibitory action and its limitations are not fully understood.
Purpose of the Study:
- To investigate the sustained inhibitory effect of dopamine on prolactin release.
- To explore the role of ascorbic acid in modulating dopamine's action on prolactin secretion.
- To examine the impact of dopamine and ascorbic acid on dopamine D2 receptor density in pituitary cells.
Main Methods:
- Primary cultured pituitary cells and GH4ZR7 cell lines were used.
- Perifusion experiments were conducted to assess prolactin release.
- Dopamine and ascorbic acid concentrations were varied to observe their effects.
- Dopamine D2 receptor density was measured.
Main Results:
- High concentrations of dopamine inhibited prolactin release for less than 60 minutes.
- Alternating dopamine and control medium suggested decreased lactotroph sensitivity to dopamine over time.
- Ascorbic acid significantly prolonged dopamine's prolactin-inhibiting effect.
- Dopamine decreased dopamine D2 receptor density, while ascorbic acid inhibited this downregulation.
Conclusions:
- Dopamine alone has limited sustained efficacy in inhibiting prolactin release.
- Ascorbic acid acts as a crucial supplementary agent, enhancing dopamine's prolactin-inhibiting function.
- Ascorbic acid's mechanism involves preventing the downregulation of dopamine D2 receptors, thereby maintaining lactotroph sensitivity.